Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review.
Leber A, Ramachandra R, Ceban F, Kwan ATH, Rhee TG, Wu J, Cao B, Jawad MY, Teopiz KM, Ho R, Le GH, Ramachandra D, McIntyre RS.
Leber A, et al. Among authors: wu j.
Expert Opin Pharmacother. 2024 Mar;25(4):467-476. doi: 10.1080/14656566.2024.2334424. Epub 2024 Mar 27.
Expert Opin Pharmacother. 2024.
PMID: 38515004